Evidence map›Paper›PMID 36259133›Full record

ArticleThe Journal of international medical research2022

Predictors of carbapenem-resistant Enterobacteriaceae (CRE) strains in patients with COVID-19 in the ICU ward: a retrospective case-control study.

Nicoleta-Dorina Vlad, Roxana Carmen Cernat, Sorina Carp, Romelia Mitan, Andrei Dumitru, Codruța Nemet, Septimiu Voidăzan, Sorin Rugină, Irina-Magdalena Dumitru

Open access · goldAbstract read
In one paragraph

Article in The Journal of international medical research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Nicoleta-Dorina VladDepartment of Infectious Diseases, Clinical Infectious Diseases Hospital, Constanța, Romania.ORCID 0000-0003-1230-6819
Roxana Carmen CernatDepartment of Infectious Diseases, Clinical Infectious Diseases Hospital, Constanța, Romania.
Sorina CarpDepartment of Infectious Diseases, Clinical Infectious Diseases Hospital, Constanța, Romania.
Romelia MitanDepartment of Infectious Diseases, Clinical Infectious Diseases Hospital, Constanța, Romania.
Andrei DumitruDepartment of Doctoral School of Medicine, Ovidius University of Constanța, Constanta, Romania.
Codruța NemetDepartment of Epidemiology, Transilvania University of Brașov, Brașov, Romania.
Septimiu VoidăzanDepartment of Epidemiology, George Emil Palade University of Medicine, Pharmacy, Science, and Technology, Targu Mures, Romania.
Sorin RuginăDepartment of Doctoral School of Medicine, Ovidius University of Constanța, Constanta, Romania.
Irina-Magdalena DumitruDepartment of Infectious Diseases, Clinical Infectious Diseases Hospital, Constanța, Romania.
Ovidius University · ROTransylvania University of Brașov · ROUniversitatea de Medicină, Farmacie, Științe și Tehnologie „George Emil Palade” din Târgu Mureș · RO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo identify carbapenem-resistant Enterobacteriaceae (CRE) in patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2; COVID-19) and to determine whether they had different risk factors for the acquisition of CRE than patients without COVID-19.

methodsThis retrospective single-centre, case-control study enrolled patients with and without COVID-19. The demographic, clinical, infection, colonization and mortality data were compared between the two groups.

resultsA total of 38 patients with COVID-19 and 26 patients without COVID-19 were enrolled. The majority of isolates detected in COVID-19 patients were

conclusionCRE strains were more common in patients with COVID-19 and they had different risks for CRE compared with patients without COVID-19.

Indexed as

Carbapenem-Resistant EnterobacteriaceaeCOVID-19Enterobacteriaceae InfectionsAnti-Bacterial AgentsCarbapenemsCase-Control StudiesHumansIntensive Care UnitsRetrospective StudiesRisk FactorsSARS-CoV-2Anti-Bacterial AgentsCarbapenemsCarbapenem-resistant EnterobacteriaceaeCOVID-19risk factors

Identifiers

PMID36259133
PMCPMC9583214
OpenAlexW4306770912

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.